Search
for
Sort by
Research 121–150 of 1000+
- Dihydrotestosterone and 5α-Reductase
- This Month in Clinical Urology
- Clinical Pharmacokinetics and Pharmacodynamics of Finasteride
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- “EGGS AT TWELVE”, HOW GIRLS BECOME BOYS AND THE DISCOVERY OF FINASTERIDE
- SOX9 in organogenesis: shared and unique transcriptional functions
- Androgen Receptor Ligands: Agonists and Antagonists
- Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient
- Finasteride treatment and neuroactive steroid formation.
- Penis Endocrinology
- Tratamiento de la Depresión durante el embarazo: perspectivas clínicas
- Endocrine control of benign prostatic hyperplasia
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Keeping Our Eye on the Ball: The American Society of Preventive Oncology in 2009
- Estrogen and androgen signaling in the pathogenesis of BPH
- Analytical methods of dutasteride: An overview
- 5α‐Reductase Inhibitors
- Metformin and Malignant Tumors: Not Over the Hill
- Successes and failures of evidence based urology
- Going Beyond Hair: Seven Simple Actions We Can Take to Help Prevent Major Illness in Our Hair Transplant Patients
- Traditional uses, phytochemistry, pharmacology, toxicity and clinical application of traditional Chinese medicine Cynoglossum amabile: a review
- Why would men use finasteride in 2005?
- Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Study on the mechanism that SNPs related to sex hormone metabolism regulate the imbalance of sex hormones and lead to BPH in rats
- Molecular mechanisms of androgen receptor functions
- 102 Methylation of CpG islands in promoter of type 2 5-α reductase and implications of finasteride resistance for BPH therapy
- Dihydrotestosteron und die Rolle der 5α-Reduktasehemmer bei der benignen Prostatahyperplasie
- Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
- 5-Alpha reductase deficiency